Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Ahn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Management and Research|July 17, 2023
Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and ConsiderationsJeffrey Ahn, Misako Nagasaka
Archives of Facial Plastic Surgery|May 19, 2004
Botulinum toxin for masseter reduction in Asian patientsJeffrey Ahn, Corinne Horn, Andrew Blitzer
Experimental Hematology & Oncology|March 2, 2019
Thyroid dysfunction from inhibitor of fibroblast growth factor receptorJeffrey Ahn, Justin Moyers, John Wong, et al.
Leukemia & Lymphoma|July 30, 2024
A case report of solitary presentations of large B-cell lymphoma of immune-privileged sites (IP-LBCL) in the testis, vitreous body, and skinJeffrey Ahn, Yi Ouyang, Graham Velasco, et al.
Pharmaceutical Research|November 28, 2012
MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiationZhongxing Liang, Jeffrey Ahn, Donna Guo, et al.
Pharmaceutical Research|November 7, 2025
Retraction Note: MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing RadiationZhongxing Liang, Jeffrey Ahn, Donna Guo, et al.
Chemmedchem|March 8, 2013
Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitorsSuazette Reid Mooring, Jin Liu, Zhongxing Liang, et al.
Laryngoscope Investigative Otolaryngology|March 5, 2020
A new office-based procedure for treatment of snoring: The S.I.Le.N.C.E. studyMichael Friedman, M Boyd Gillespie, Faramarz A Shabdiz, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 30, 2014
Clinical outcomes and complications associated with TORS for OSAHS: a benchmark for evaluating an emerging surgical technology in a targeted application for benign diseaseClaudio Vicini, Filippo Montevecchi, Aldo Campanini, et al.
Tissue Engineering. Part B, Reviews|November 7, 2009
Facial reconstruction by biosurgery: cell transplantation versus cell homingJeremy J Mao, Michael S Stosich, Eduardo K Moioli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Management and Research|July 17, 2023
Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and ConsiderationsJeffrey Ahn, Misako Nagasaka
Archives of Facial Plastic Surgery|May 19, 2004
Botulinum toxin for masseter reduction in Asian patientsJeffrey Ahn, Corinne Horn, Andrew Blitzer
Experimental Hematology & Oncology|March 2, 2019
Thyroid dysfunction from inhibitor of fibroblast growth factor receptorJeffrey Ahn, Justin Moyers, John Wong, et al.
Leukemia & Lymphoma|July 30, 2024
A case report of solitary presentations of large B-cell lymphoma of immune-privileged sites (IP-LBCL) in the testis, vitreous body, and skinJeffrey Ahn, Yi Ouyang, Graham Velasco, et al.
Pharmaceutical Research|November 28, 2012
MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiationZhongxing Liang, Jeffrey Ahn, Donna Guo, et al.
Pharmaceutical Research|November 7, 2025
Retraction Note: MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing RadiationZhongxing Liang, Jeffrey Ahn, Donna Guo, et al.
Chemmedchem|March 8, 2013
Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitorsSuazette Reid Mooring, Jin Liu, Zhongxing Liang, et al.
Laryngoscope Investigative Otolaryngology|March 5, 2020
A new office-based procedure for treatment of snoring: The S.I.Le.N.C.E. studyMichael Friedman, M Boyd Gillespie, Faramarz A Shabdiz, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|April 30, 2014
Clinical outcomes and complications associated with TORS for OSAHS: a benchmark for evaluating an emerging surgical technology in a targeted application for benign diseaseClaudio Vicini, Filippo Montevecchi, Aldo Campanini, et al.
Tissue Engineering. Part B, Reviews|November 7, 2009
Facial reconstruction by biosurgery: cell transplantation versus cell homingJeremy J Mao, Michael S Stosich, Eduardo K Moioli, et al.
Pageof 1